NEMAURA MEDICAL INC. Accretion Expense
NEMAURA MEDICAL INC. reported Accretion Expense of $0 for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2023-08-14
- NEMAURA MEDICAL INC. accretion expense for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- NEMAURA MEDICAL INC. accretion expense for the quarter ending 2022-06-30 was $1.45M, a 15.73% decline year-over-year.
- NEMAURA MEDICAL INC. accretion expense for the quarter ending 2022-03-31 was $1.52M, a 40.28% increase year-over-year.
- NEMAURA MEDICAL INC. accretion expense for the quarter ending 2021-12-31 was $1.64M, a 333.39% increase year-over-year.
- NEMAURA MEDICAL INC. accretion expense for fiscal 2022 was $6.67M, a 232.06% increase from fiscal 2021.
- NEMAURA MEDICAL INC. accretion expense for fiscal 2021 was $2.01M.
- NEMAURA MEDICAL INC. accretion expense for fiscal 2020 was $0.00.
| Period end | Accretion Expense 3 month | Accretion Expense 3 month as first filed | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 12 month |
|---|---|---|---|---|---|
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 | ||||
| 2022-06-30 | $1.45M 10-Q · filed 2023-08-14 | $1.77M 10-Q · filed 2022-08-12 | $2.98M derived: sum of 2 quarters · filed 2023-08-14 | $4.62M derived: sum of 3 quarters · filed 2023-08-14 | $6.40M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-29 | $3.16M derived: sum of 2 quarters · filed 2022-06-29 | $4.94M derived: sum of 3 quarters · filed 2022-06-29 | $6.67M 10-K · filed 2022-06-29 | |
| 2021-12-31 | $1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-11 | $3.42M derived: sum of 2 quarters · filed 2022-02-11 | $5.14M 10-Q · filed 2022-02-11 | $6.23M derived: sum of 4 quarters · filed 2023-02-24 | |
| 2021-09-30 | $1.78M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2021-11-12 | $3.50M 10-Q · filed 2021-11-12 | $4.59M derived: sum of 3 quarters · filed 2023-02-24 | $4.97M derived: sum of 4 quarters · filed 2023-02-24 | |
| 2021-06-30 | $1.72M 10-Q/A · filed 2023-02-24 | $20.00K 10-Q · filed 2021-08-16 | $3.19M derived: sum of 3 quarters · filed 2023-02-24 | $3.38M derived: sum of 4 quarters · filed 2023-02-24 | |
| 2021-03-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-29 | $1.47M derived: sum of 2 quarters · filed 2022-06-29 | $1.65M derived: sum of 3 quarters · filed 2022-06-29 | $2.01M 10-K · filed 2022-06-29 | |
| 2020-12-31 | $378.22K 10-Q · filed 2021-02-12 | $566.80K derived: sum of 2 quarters · filed 2021-02-12 | $920.65K 10-Q · filed 2022-02-11 | $755.38K derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-09-30 | $188.58K 10-Q · filed 2020-11-13 | $542.43K 10-Q · filed 2021-11-12 | $377.16K derived: sum of 3 quarters · filed 2021-08-16 | $377.16K derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-06-30 | $188.58K 10-Q · filed 2021-08-16 | $188.58K derived: sum of 2 quarters · filed 2021-08-16 | $188.58K derived: sum of 3 quarters · filed 2021-08-16 | $188.58K derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-29 | $0.00 derived: sum of 2 quarters · filed 2021-06-29 | $0.00 derived: sum of 3 quarters · filed 2021-06-29 | $0.00 10-K · filed 2021-06-29 | |
| 2019-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-12 | $0.00 derived: sum of 2 quarters · filed 2021-02-12 | $0.00 10-Q · filed 2021-02-12 | ||
| 2019-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-13 | $0.00 10-Q · filed 2020-11-13 | |||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-14 |